23.06.2008 19:51:00
|
Medis Technologies Appoints Frank Romero as Sr. VP Sales and Market Development
Medis Technologies Ltd. (NASDAQ:MDTL) announced today that it
appointed Mr. Frank Romero as its Sr. VP of Sales and Market
Development. Mr. Romero brings to Medis 15 years of broad industry
experience that spans product management, marketing, and sales
development in the telecommunications and IT industries. Mr. Romero
joins Medis from Hewlett-Packard Corporation where he most recently held
the position of Group Manager, Accessories & Options, for the iPAQ
handheld business. In that position, he led and managed the iPAQ
accessories portfolio. He developed the category roadmap and made
significant contributions in business planning, partner and product
development efforts, and creating sales and marketing tools for the
accessory products for iPAQ smart phones, iPAQ portable GPS navigation
devices, and iPAQ PDA handhelds.
Prior to joining HP, Mr. Romero held senior positions in product
management, marketing, and business development at Philips Electronics,
Handspring, and Epson where he helped to bring a variety of products to
market.
Mr. Romero received his MBA from the University of Chicago, Graduate
School of Business, and also acquired international business experience
at one of Europe's prestigious business programs, Instituto de Estudios
Superiores de las Empresas (IESE) in Barcelona, Spain. He graduated from
the University of California, Los Angeles (UCLA), with a Bachelors
degree in electrical engineering. Mr. Romero and his family live in the
San Francisco bay area.
"Mr. Romero is a seasoned product management, marketing, and sales
professional across a variety of consumer technology product categories
and sales channels," said Robert K. Lifton, CEO, Medis Technologies. "We
at Medis are delighted to add someone with such a distinguished
background and body of knowledge relating to the mobile device and
accessories market to the Medis management team."
"I am looking forward to joining Medis Technologies in expanding the
sales and marketing program for the Medis 24/7 line of products," said
Frank Romero. "The Medis fuel cell platform offers a unique opportunity
for developing a broad line of fuel cell products capable of providing
power for a wide range of applications for laptops, stand by power for
home & office use, and many vertical markets. I am excited about my
participation in a company at the forefront of "green" fuel cell
technologies and its commitment to the environment."
About Medis Technologies Ltd.
Medis Technologies' primary focus is on its fuel cell technology. Its
business strategy is to sell its products to end users through branded
OEM partnerships, retail outlets, service providers and to the military
and other markets. Medis' majority owned and publicly traded subsidiary,
Cell Kinetics Ltd., is engaged in the development and commercialization
of the CKChip, a unique cell carrier platform intended for simultaneous
fluoroscopic monitoring and analysis of thousands of individual living
cells over time.
"All registered and/or unregistered trademarks are the property of
their respective owners." This press release may contain forward-looking statements, which are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. In some cases you can
identify those so-called "forward looking
statements” by words such as "may,” "will,” "should,” "expects,” plans,” "targets,” "believes,” "anticipates,” "estimates,” "predicts,” "potential,”
or "continue” or
the negative of those words and other comparable words. These forward
looking statements are subject to risks and uncertainties, product
tests, commercialization risks, availability of financing and results of
financing efforts that could cause actual results to differ materially
from historical results or those anticipated.
This press release is available on Medis’ web
site at www.medistechnologies.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Medis Technologies Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |